Gene · 6921
NIH grants1,232
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,232
Download this page as JSON| Grant | Title | ELOC papers | Newest fiscal year |
|---|---|---|---|
| U01CA176058 | The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center | 2 | 2021 |
| ZIABC011124 | Oncogenic Met Signaling in Urologic Malignancies | 2 | 2021 |
| F30AA026497 | The Role and Mechanisms of Clic4 in Modifying Ethanol-Related Behaviors | 1 | 2021 |
| F30AI149928 | Complete mapping of the functional and antigenic effects of mutations to Lassa virus glycoprotein | 1 | 2021 |
| F30CA228208 | Optimal BET inhibitor combination therapies in triple negative breast cancer | 1 | 2021 |
| F30CA239476 | Investigating functional interactions with KRAS G12C inhibition | 1 | 2021 |
| F31HG010820 | Interrogating Enhancer Function and Cooperation by Systematic Perturbation of Transposable Elements | 1 | 2021 |
| F32AG063487 | Mechanisms of tau misfolding in neurons elucidated by deep mutational scanning and CRISPR screening | 1 | 2021 |
| F32AI150351 | Molecular Determinants of Retroviral Capsid Morphology using a Novel Imaging Approach | 1 | 2021 |
| F32GM133144 | Heterogenous cytoplasmic RNA-protein aggregates enhance cellular survival under stress | 1 | 2021 |
| K99GM138753 | Proton Conduction Pathways in Proton Channel Proteins | 1 | 2021 |
| P01AI131346 | Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy | 1 | 2021 |
| P20GM103640 | Oklahoma COBRE in Structural Biology | 1 | 2021 |
| P41GM103533 | Comprehensive Biology: Exploiting the Yeast Genome | 1 | 2021 |
| P50AI150464 | Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV (CHEETAH Center) | 1 | 2021 |
| R01AI127447 | Defining the role of Host Hsp70 Subnetworks in Dengue Virus Replication | 1 | 2021 |
| R01AI128214 | Protein secretion in bacterial pathogens | 1 | 2021 |
| R01CA047006 | Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation | 1 | 2021 |
| R01CA068377 | Maintaining Genome Integrity and Suppressing Tumorigenesis by the 3M-CUL7-CUL9-p53 | 1 | 2021 |
| R01CA076584 | F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/grants?page=21